Le Wei-Bo, Shi Jing-Song, Zhang Tao, Liu Lei, Qin Hua-Zhang, Liang ShaoShan, Zhang Yuan-Wei, Zheng Cun-Xia, Jiang Song, Qin Wei-Song, Zhang Hai-Tao, Liu Zhi-Hong
National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China; and.
BGI-Shenzhen, Shenzhen, China.
J Am Soc Nephrol. 2017 May;28(5):1642-1650. doi: 10.1681/ASN.2016060644. Epub 2016 Dec 27.
Idiopathic membranous nephropathy (MN) is associated with HLA; however, the HLA allele involved remains unknown. To identify the HLA risk alleles associated with phospholipase A2 receptor (PLA2R)-related MN in the Chinese population, we sequenced the entire MHC region in DNA samples from 99 patients with PLA2R-related MN, 50 patients with PLA2R-unrelated MN, and 100 healthy subjects. Two HLA risk alleles, HLA-DRB115:01 and HLA-DRB302:02, independently and strongly associated with an increased risk of PLA2R-related MN. After adjusting for HLA-DRB115:01 and HLA-DRB302:02, no other alleles showed significant association with PLA2R-related MN. A replication study in an independent cohort of 293 participants with PLA2R-related MN and 285 healthy controls validated these findings. In a joint analysis, a multivariate logistic regression model confirmed that HLA-DRB115:01 (odds ratio [OR], 24.9; 95% confidence interval [95% CI], 15.3 to 42.6; =2.3×10) and HLA-DRB302:02 (OR, 17.7; 95% CI, 11.0 to 30.3; =8.0×10) independently and strongly associated with PLA2R-related MN. As many as 98.7% of patients with PLA2R-related MN, compared with 43.9% of control subjects, carried at least one HLA risk allele. Subjects with either risk allele had higher odds of developing PLA2R-related MN than those without a risk allele (OR, 98.9; 95% CI, 44.4 to 281.7; =2.5×10). These HLA risk alleles also associated with the age at disease onset in patients with PLA2R-related MN. In conclusion, our findings provide clear evidence that the HLA-DRB115:01 and HLA-DRB302:02 alleles independently and strongly associate with PLA2R-related MN in the Chinese population.
特发性膜性肾病(MN)与人类白细胞抗原(HLA)相关;然而,所涉及的HLA等位基因仍不清楚。为了在中国人群中鉴定与磷脂酶A2受体(PLA2R)相关的MN的HLA风险等位基因,我们对99例PLA2R相关MN患者、50例PLA2R不相关MN患者和100名健康受试者的DNA样本中的整个主要组织相容性复合体(MHC)区域进行了测序。两个HLA风险等位基因,HLA-DRB115:01和HLA-DRB302:02,独立且强烈地与PLA2R相关MN的风险增加相关。在对HLA-DRB115:01和HLA-DRB302:02进行校正后,没有其他等位基因显示与PLA2R相关MN有显著关联。在一个由293名PLA2R相关MN参与者和285名健康对照组成的独立队列中进行的重复研究验证了这些发现。在一项联合分析中,多变量逻辑回归模型证实HLA-DRB115:01(比值比[OR],24.9;95%置信区间[95%CI],15.3至42.6;P = 2.3×10⁻²³)和HLA-DRB302:02(OR,17.7;95%CI,11.0至30.3;P = 8.0×10⁻¹²)独立且强烈地与PLA2R相关MN相关。与43.9%的对照受试者相比,多达98.7%的PLA2R相关MN患者携带至少一个HLA风险等位基因。携带任一风险等位基因的受试者发生PLA2R相关MN的几率高于没有风险等位基因的受试者(OR,98.9;95%CI,44.4至281.7;P = 2.5×10⁻¹²)。这些HLA风险等位基因也与PLA2R相关MN患者的发病年龄相关。总之,我们的研究结果提供了明确的证据,表明HLA-DRB115:01和HLA-DRB302:02等位基因在中国人群中独立且强烈地与PLA2R相关MN相关。